Latest 10-K annual reports

NYSE
Medtronic plc reported a 4% increase in net sales and a significant rise in GAAP net income for fiscal year 2025, fueled by strong performance in its Cardiovascular, Neuroscience, and Diabetes segments, while also announcing plans to separate its Diabetes business.
NASDAQ
Smith & Wesson Brands, Inc. announced a substantial decrease in net sales and net income for fiscal year 2025, driven by lower consumer demand and increased operational costs, while navigating a complex legal and regulatory landscape.
NASDAQ
Modular Medical, Inc., a pre-revenue medical device company, has received FDA clearance for its MODD1 insulin pump and plans initial shipments by September 2025, while acknowledging substantial doubt about its ability to continue as a going concern without further capital.
NYSE
Oracle Corporation announced robust revenue growth driven by its cloud services in fiscal year 2025, alongside significant capital expenditures for infrastructure expansion and ongoing strategic investments in AI, despite reporting negative free cash flow.
NYSE
The J. M. Smucker Company recorded a significant net loss of $1.23 billion in fiscal year 2025, primarily due to substantial goodwill and intangible asset impairment charges related to its Hostess Brands acquisition, despite a 7% increase in net sales.
NASDAQ
Borealis Foods Inc. has filed an Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to correct beneficial ownership information for directors, executive officers, and a significant shareholder.
NASDAQ
GSI Technology, a semiconductor memory solutions provider, reported a significantly reduced net loss for fiscal year 2025, driven by cost-cutting measures and a one-time gain from a property sale, while actively pursuing strategic alternatives and advancing its AI-focused Associative Processing Unit technology.
GMS Inc. announced a substantial 58.2% decrease in net income and an 18.6% drop in Adjusted EBITDA for fiscal year 2025, primarily due to softening market demand, deflationary pricing in steel framing, and a $42.5 million goodwill impairment charge, despite a slight increase in net sales driven by strategic acquisitions.
OTC.Pink
Vocodia Holdings Corp has filed an amendment to its 2024 annual report, restating financial statements due to a misclassified transaction, revealing increased net losses and raising substantial doubt about its ability to continue as a going concern.
Longevity Health Holdings, Inc. filed an amended annual report revealing substantial net losses, negative working capital, and ongoing Nasdaq delisting challenges, despite recent capital raises and a strategic pivot to cosmetic bio-aesthetics.
NASDAQ
Vistagen Therapeutics, a clinical-stage biopharmaceutical company, reported a significant increase in net losses and cash burn for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, despite positive clinical progress for its lead drug candidate, fasedienol, and other pipeline assets.
NYSE
La-Z-Boy Incorporated reported a 3% increase in consolidated sales for fiscal year 2025, reaching $2.11 billion, but saw a 9.9% decline in operating income to $135.8 million, primarily due to a significant goodwill impairment charge in its UK operations and higher selling, general, and administrative expenses.
NASDAQ
Sonoma Pharmaceuticals, Inc. reported a net loss of $3.457 million for fiscal year 2025, despite a 12% increase in total revenue to $14.288 million, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
Sky Quarry Inc. has filed an Amendment No. 2 to its Annual Report on Form 10-K for the year ended December 31, 2024, solely to incorporate updated exhibits detailing its securities and the amended 2020 Stock Plan.
OTC.Pink
DATA443 Risk Mitigation, Inc. reported a significant increase in net loss and a worsening working capital deficiency for fiscal year 2024, prompting an auditor's going concern warning, despite strategic acquisitions and efforts to enhance product offerings.
NASDAQ
Outdoor Holding Company, formerly AMMO, Inc., reported a significant net loss and revenue decline in fiscal year 2025, driven by the divestiture of its Ammunition segment and substantial legal and professional expenses, while grappling with an ongoing SEC investigation and material weaknesses in internal controls.
OTC.Pink
DATA443 Risk Mitigation, Inc. (ATDS) reported a significant increase in net loss for fiscal year 2024, coupled with a decline in revenue and a substantial working capital deficiency, raising significant doubts about its ability to continue as a going concern.
OTC.Pink
Goldenstone Acquisition Limited, a SPAC, reported a significant decline in net income and cash reserves for fiscal year 2025, facing substantial doubt about its ability to continue as a going concern while pursuing a delayed business combination with Infintium Fuel Cell Systems and having been delisted from Nasdaq.
NASDAQ
Iveda Solutions, Inc. has filed an amended annual report (10-K/A) to reflect restatements of prior financial periods, reporting continued net losses and a 'going concern' opinion, despite strategic focus on smart city technologies.
NASDAQ
Digital Turbine, Inc. reported a significant revenue decrease and net loss for fiscal year 2025, while securing a short-term extension on its credit facility and actively pursuing a comprehensive debt refinancing strategy.
OQB
Global AI, Inc. reported a substantial increase in net loss and negative cash flow for fiscal year 2024, raising significant doubts about its ability to continue as a going concern, despite its strategic shift towards AI product development and technology acquisitions.
OID
Brownies Marine Group, Inc. reported an 8.11% increase in total net revenues and a significant improvement in gross profit margin for the fiscal year ended December 31, 2024, despite incurring a net loss and facing substantial doubt about its ability to continue as a going concern.
DT Cloud Acquisition Corporation filed an amendment to its annual report, providing updated information on its proposed business combination with Maius Pharmaceutical, extensions to its acquisition deadline, and changes in executive leadership.
NYSE
Brown-Forman Corporation reported a 5% decrease in net sales and a 22% decline in operating income for fiscal year 2025, primarily due to divestitures and macroeconomic headwinds, while focusing on long-term strategic growth initiatives.
OTC.Pink
The Crypto Company's latest 10-K filing reveals a significant drop in consulting revenue and a substantial net loss for 2024, alongside a negative working capital position, prompting a "going concern" warning from its auditors.
NASDAQ
Freedom Holding Corp. announced a 23% increase in total net revenue to $2.05 billion for fiscal year 2025, driven by growth in brokerage and insurance segments, despite a significant 77% decrease in net income attributed to unrealized trading losses and increased operational investments.
OTC.Pink
Aura Systems, Inc. reported a staggering $21.1 million net loss for Fiscal 2025, a significant increase from the prior year, raising substantial doubt about its ability to continue as a going concern due to mounting debt and operational cash burn.
NASDAQ
Riverview Bancorp, Inc. reported a rise in net income to $4.9 million for fiscal year 2025, driven by strategic loan portfolio expansion and non-interest income growth, despite a competitive interest rate environment and shifts in deposit composition.
NASDAQ
Friedman Industries, a steel manufacturer and processor, reported a substantial decrease in net earnings and sales for fiscal year 2025, navigating volatile steel prices with the aid of successful hedging strategies, while also extending its asset-based lending facility.
OQX
IEH Corporation announced a significant turnaround in its fiscal year ended March 31, 2025, reporting a 33.7% increase in revenue and a return to net income, despite a notable decrease in order backlog and persistent macroeconomic and regulatory challenges.